Medistim ASA

OB:MEDI Stock Report

Market Cap: NOK 2.7b

Medistim Future Growth

Future criteria checks 2/6

Medistim is forecast to grow earnings and revenue by 4.1% and 3.2% per annum respectively while EPS is expected to grow by 4.1% per annum.

Key information

4.1%

Earnings growth rate

4.1%

EPS growth rate

Medical Equipment earnings growth18.8%
Revenue growth rate3.2%
Future return on equityn/a
Analyst coverage

Low

Last updated26 Oct 2024

Recent future growth updates

Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Oct 28
Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 19
Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 04
Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon

Dec 13
Medistim ASA's (OB:MEDI) Shares May Have Run Too Fast Too Soon

Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Oct 28
Medistim ASA Just Missed Earnings - But Analysts Have Updated Their Models

Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Aug 19
Medistim ASA Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Mar 04
Medistim ASA Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts

Nov 10
One Medistim ASA (OB:MEDI) Analyst Has Been Cutting Their Forecasts

What Does Medistim ASA's (OB:MEDI) Share Price Indicate?

Dec 14
What Does Medistim ASA's (OB:MEDI) Share Price Indicate?

Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?

Sep 06
Should You Be Adding Medistim (OB:MEDI) To Your Watchlist Today?

A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)

Jun 14
A Look At The Intrinsic Value Of Medistim ASA (OB:MEDI)

Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75

Apr 21
Medistim (OB:MEDI) Is Increasing Its Dividend To kr3.75

Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year

Mar 31
Medistim (OB:MEDI) Is Paying Out A Larger Dividend Than Last Year

Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are

Mar 05
Statutory Profit Doesn't Reflect How Good Medistim's (OB:MEDI) Earnings Are

Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year

Mar 01
Medistim's (OB:MEDI) Shareholders Will Receive A Bigger Dividend Than Last Year

Medistim (OB:MEDI) Is Reinvesting To Multiply In Value

Jan 11
Medistim (OB:MEDI) Is Reinvesting To Multiply In Value

Medistim (OB:MEDI) Might Become A Compounding Machine

Sep 29
Medistim (OB:MEDI) Might Become A Compounding Machine

Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today

Sep 07
Here's Why I Think Medistim (OB:MEDI) Might Deserve Your Attention Today

Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean

May 17
Here's What Medistim's (OB:MEDI) Strong Returns On Capital Mean

Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Mar 19
Is Medistim ASA's(OB:MEDI) Recent Stock Performance Tethered To Its Strong Fundamentals?

Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 02
Medistim ASA (OB:MEDI) Just Reported And Analysts Have Been Lifting Their Price Targets

Here's What You Should Know About Medistim ASA's (OB:MEDI) 1.1% Dividend Yield

Feb 19
Here's What You Should Know About Medistim ASA's (OB:MEDI) 1.1% Dividend Yield

A Look Into Medistim's (OB:MEDI) Impressive Returns On Capital

Jan 21
A Look Into Medistim's (OB:MEDI) Impressive Returns On Capital

Have Insiders Been Selling Medistim ASA (OB:MEDI) Shares?

Dec 27
Have Insiders Been Selling Medistim ASA (OB:MEDI) Shares?

Medistim (OB:MEDI) Has Rewarded Shareholders With An Exceptional 375% Total Return On Their Investment

Dec 10
Medistim (OB:MEDI) Has Rewarded Shareholders With An Exceptional 375% Total Return On Their Investment

Earnings and Revenue Growth Forecasts

OB:MEDI - Analysts future estimates and past financials data (NOK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026583114N/AN/A1
12/31/20255611101011161
12/31/20245471091051351
9/30/202454210287117N/A
6/30/202453310499128N/A
3/31/2024526103105135N/A
12/31/202352110483113N/A
9/30/202352711786107N/A
6/30/20235191167496N/A
3/31/20234991167192N/A
12/31/202248611492113N/A
9/30/202245998115127N/A
6/30/202244492126138N/A
3/31/202243193120132N/A
12/31/202141891116127N/A
9/30/20213978890101N/A
6/30/2021378846373N/A
3/31/2021356705970N/A
12/31/2020356696374N/A
9/30/2020358716882N/A
6/30/2020360747891N/A
3/31/2020371757892N/A
12/31/2019357706780N/A
9/30/2019363796278N/A
6/30/2019355735874N/A
3/31/2019338644460N/A
12/31/2018323573956N/A
9/30/2018305465367N/A
6/30/201830348N/A61N/A
3/31/201829645N/A54N/A
12/31/201729648N/A62N/A
9/30/201728141N/A41N/A
6/30/201727439N/A36N/A
3/31/201727241N/A45N/A
12/31/201626339N/A30N/A
9/30/201627445N/A35N/A
6/30/201626845N/A37N/A
3/31/201625843N/A38N/A
12/31/201525040N/A45N/A
9/30/201524239N/A47N/A
6/30/201523337N/A48N/A
3/31/201522333N/A51N/A
12/31/201421431N/A49N/A
9/30/201420028N/A37N/A
6/30/201419324N/A37N/A
3/31/201419426N/A27N/A
12/31/201319027N/A26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEDI's forecast earnings growth (4.1% per year) is above the savings rate (2.4%).

Earnings vs Market: MEDI's earnings (4.1% per year) are forecast to grow slower than the Norwegian market (9.6% per year).

High Growth Earnings: MEDI's earnings are forecast to grow, but not significantly.

Revenue vs Market: MEDI's revenue (3.2% per year) is forecast to grow faster than the Norwegian market (2.2% per year).

High Growth Revenue: MEDI's revenue (3.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MEDI's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 15:27
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medistim ASA is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Magnus GranerødBeringer Finance AB
Karl NorénDanske Bank
Simen MortensenDNB Markets